One of the salient pathological features of rheumatoid arthritis is synovial cell proliferation with bone erosion. Despite extensive investigation, the factors essential for synovial cell proliferation remain to be identified. Recent studies suggest that human T cell leukemia virus type I (HTLV-I) may play an important role in synovial overgrowth observed in patients with one type of chronic inflammatory synovitis. In order to confirm and extend these observations, we have established synovial cell clones (SCCs) from three HTLV-I carriers who demonstrated synovial overgrowth but were otherwise asymptomatic. HTLV-I proviral DNA randomly integrated into the cellular genome was present in 20-30% of SCCs. The SCCs carrying HTLV-I proviral DNA and expressing the tax gene exhibited high levels of proliferative potential. HTLV-I was found to function as a transcriptional trans-activator in these SCCs. Moreover, transfection of the tax expression plasmid into SCCs resulted in the same phenotype of increased proliferation and cytokine expression as exhibited by HTLV-I provirus-carrying and tax-expressing SCCs. These data suggest that tax plays a critical role not only in leukemogenesis but also in synovial overgrowth in humans. (J. Clin. Invest. 1993. 92:186-193.) Key words: human T cell leukemia virus type I * rheumatoid arthritis * synovial cell * synovial overgrowth * tax gene as the causative agent of adult T cell leukemia (3, 4) and is found to be closely associated with a nonmalignant neurologi-Address reprint requests to Dr. Kusuki Nishioka, Division ofRheumatology and Molecular Immunology,
Introduction
Human T cell leukemia virus type I (HTLV-I)' ( 1, 2) is known cal disorder termed tropical spastic paraparesis or HTLV-I-associated myelopathy (TSP/HAM) (5, 6) . Recently, a chronic inflammatory arthropathy was found in patients with chronic adult T cell leukemia (ATL) (7, 8) and TSP/HAM (9) and among HTLV-I carriers (10, 11) . We have thus likened it to HTLV-I-associated arthropathy (HAAP) (10, 12) . In the course of investigations on the relationship between HTLV-I infection and synovial cell proliferation, we found that IgM-as well as IgG-type anti-HTLV-I antibodies persist in the synovial fluid of affected joints but not in sera in patients with this arthropathy (8) . We also reported the presence and expression ofthe proviral HTLV-I genome in non-T cell synovial cells of HAAP patients ( 13 ) . Moreover, transgenic mice that carried and preferentially expressed the HTLV-I pX gene in the articular lesion had shown a synovial overgrowth resembling that seen in a patient with RA ( 14) . These observations raise the possibility that integration ofproviral HTLV-I DNA into synovial cells may play a central role in the pathogenesis of HAAP. We have attempted here to establish whether the synovial overgrowth of HAAP might result from HTLV-I integration. Our data indicate that HTLV-I tax expression causes synovial cell proliferation in humans. These findings provide important insights into the biological function of the HTLV-I tax gene.
Methods
Establishment ofnon-T cell synovial cell clones (SCCs) and detection ofHTL V-Iproviral DNA. Three patients with HAAP were examined in this study after obtaining their informed consent. Their clinical manifestations have already been described (11) . The limiting dilution method was employed to establish non-T cell SCCs from these patients. Lymphocyte-depleted synovial cells were immediately prepared to prevent in vitro HTLV-I transmission as described ( 13, 15) . Briefly, synovial tissues were obtained by biopsy from affected joints under arthroscopy. These tissues were minced into small pieces, washed three times in PBS, and treated with PBS-0.25% trypsin for 20 min at 37°C. These cells were then diluted to five cells per milliliter with the following culture medium: HAM F-12 medium (Gibco Laboratories, Grand Island NY) supplemented with 10% FCS, 5 X I0-M 2-mercaptoethanol, 100 U/ml of penicillin, and 100 ,g/ml of streptomycin). Each 0.1 ml ofcell suspension was dispensed into four 96-well flat-bottomed culture plates (0.5 cells per well). When the cell culture reached confluency (about 5 X 103 cells per well) or on the 60th day ofculture, one half of the cells were harvested from each well and the genomic DNA isolated by SDS/proteinase K digestion and subsequent phenol and chloroform extraction. The PCR ( 16) was applied for the detection of proviral DNA. Briefly, we used two primer sets: one is specific for consisted of 25 ng of DNA sample, 50 pmol of each primer, 200 ,mol of each deoxynucleotide triphosphate, and 2.0 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, CT). This mixture was subjected to 40 cycles ofdenaturation for 1 min at 940C, primer annealing for 2 min at 60'C, and chain elongation for 3 min at 720C using a DNA thermal cycler (Perkin-Elmer Cetus). One fifth ofthe amplified DNA was then separated by 1.5% agarose gel electrophoresis and visualized by ethidium bromide fluorostaining. We regarded the SCCs that exhibited positive amplification from both HTLV-I proviral DNA and HLA DQ[3 as "integrated." Among the SSCs that were amplified, only HLA DQ(3 was considered to be "nonintegrated SCCs." These results were reproducible and neither HTLV-I nor HLA DQf3 were observed in the "no DNA" samples that had been amplified without DNA as a negative control for each PCR reaction.
Colony formation assay. 1,000 cells each from the four kinds of SCCs ( Fig. 1 ) were cultured in semisolid medium containing 0.33% agarose. After 14 d ofculture, the number ofcolonies that consisted of > 10 cells were counted under microscopy.
Detection ofc-fos, IL-i][, and IL-6 mRNA under starvation conditions. 5 X 105 cells from individual SCCs were cultured under serumfree conditions for 48 h to exclude the effect of serum factors that can induce c-fos transcripts. At this point, the SCCs were harvested and total RNA was isolated using the acid guanidine thiocyanate-phenol/ chloroform method ( 19) . After treatment with RNase-free DNase and quantification, 10-fold titrated RNA (20 pg-200 ng) was converted to cDNA by reverse transcriptase. The amplification procedure consisted of 35 cycles (94°C for 1 min, 62°C for 1 min, 72°C for 1 min) with the following oligonucleotide primer sets: Fos 1 (5-889ATGATGTTCTCG-GGCTTCAACG9'0-3)andFos3( 5-1992TCCTGTCATGGTCTTCAC-AACG'971-3), specific for c-fos (GeneBank accession nos. K00650 and M 16287); IL-l-1 (5-'56'GAAGCTGATGGCCCTAAACAGATG154-3) and IL-1-2 (5-4374GGTGCATCGTGCACATAAGCCTCG4351'-3), specific for IL-I13 (GeneBank accession no. M15840); IL-6-1 (5-'396GCGCCTTCGGTCCAGTTGCCTTCTC 1420o3) and IL-6-2 (5-2673CCTCTTTGCTGCTTrCACACATG2651'-3), specific for IL-6 (GeneBank accession no. Y0008 1); and BAC1 (5-'417AAGAGAGGC-ATCCTCACCCT'490-3) and BAC2 (5-2129TACATGGCTGGGGTG-TTGAA2110-3), specific for [3-actin (GeneBank accession nos. FCS were cultured for 48 h. Actinomycin-D (5 Ag/ml) was then added to the cultures. Total RNA was recovered at the intervals of 0, 60, 120, and 180 min. Cell viabilities before RNA recovery were always > 90%. 5% of the converted cDNAs were amplified with 5'biotinylated Fos 1 and Fos 3 oligonucleotide primers. 20% of the amplified products ( 10 Ml) were electrophoresed on a 6% polyacrylamide gel and transferred to Imobilon-S (MilliGen/Biosearch, Burlington, MA). Transferred biotinylated products were visualized using the streptavidin/biotinylated alkaline phosphatase/chemiluminescent substrate system (Plex luminescent kit, MilliGene/Biosearch). Densitometry was performed on the autoradiograms and percent inhibition was expressed as (absorbance units at the indicated time divided by that at 0 time) x 100, was plotted against time to estimate the half-life of c-fos mRNA.
Analysis of the mode of HTLV-I integration into SCCs-I by the modified ligand-mediated PCR (LM-PCR). We performed the modi- Comparison of tax gene expression levels of SCCs-I and III. To examine the relationship of tax expression to synovial cell proliferation, we compared the level of tax gene expression between SCCs-I and SCCs-III by reverse transcription (RT)-PCR analysis for tax mRNA (22) . SCCs-I and -III were cultured in the presence or absence of 10% FCS. RT-PCR using RPX3 (5-5096ATCCCGTGGAGACTCCTC-AA5115-3) and PRX4 (5-7357AACACGTAGACTGGGTATCC7338-3) specific for HTLV-I taxi/rex] (GeneBank accession no. J02029) was performed as described (22) .
In vitro transfection analysis of the tax expressing plasmid into SCCs-IV. The in vitro transfection assay was carried out with the following plasmids: the tax expression plasmid pH2R4OM driven by the SV40 early promoter, and the pH2R neo plasmids containing a bacterial neomycin resistance gene alone (23) (24) (25) 
Results
Establishment ofnon-T cell synovial cell clones and detection of HTL V-I proviral DNA. We established 131 SCCs from a patient with HAAP by means of a limiting dilution culture of up to 60 d. As shown in Fig. 1 , the SCCs were classified into four types (I-IV). Of these four, type 1 spite of starvation conditions, SCCs-I continued to grow and the amplified signal from c-fos mRNA was obtained even from I0-5 diluted (20 pg) mRNA. The mRNAs of IL-1 :l and IL-6 were also detected only in SCCs-I ( Fig. 2 B and Table I ).
Study ofthe half-life ofc-fos mRNA in individual SCCs. To search out a possible mechanism for potentiated c-fos mRNA expression, we determined the half-life of c-fos mRNA expression in each type of SCC. As shown in Fig. 3 , the half-life was 52 min for SCCs-I under serum-free conditions. In the presence of 10% FCS, the half-lives for SCCs-I and -II were 51 and 58 min, respectively. It is possible that c-fos mRNA was transcriptionally activated rather than posttranscriptionally stabilized in SCCs-I. Furthermore, those ofIL-1p3 and IL-6 were also found to be transcriptionally activated (data not shown).
Analysis ofthe mode ofHTL V-I integration into SCCs-I by the LM-PCR. Next, we determined the manner of integration ofHTLV-I into SCCs using the modified LM-PCR to assess the clonality of SCCs-I. We found that the sizes of the amplified DNA products from six SCCs-I ( Fig. 4 Colonyformation assay. We performed the colony formation assay to assess the anchorage-independent growth capacity and altered growth characteristics. We found that 3.18±0.55% of SCCs-I formed colonies (Fig. 2 A) . However, only 0.04±0.02% of SCC-II were capable of forming colonies. Colony formation was not observed with SCCs-IIIand -IV.
, top) and those of PCR
Detection ofc-fos, IL-If, and IL-6 mRNA under starvation conditions. As shown in Fig. 2 B , the four kinds ofSCCs yielded nearly the same amount of amplified mRNA for 3-actin. In products representing sequences adjoining the 5'HTLV-I LTR U3 region were substantially different from one to another (Fig. 4, bottom) . These results indicate that most SCCs that had randomly integrated the HTLV-I genome were oligoto polyclonal populations. These data suggest that HTLV-I did not act as a cis-element by site-specific integration, but acted in trans to promote synovial cell proliferation. Comparison oftax gene expression levels ofSCCs-I andIII. Taken together, all of our current observations demonstrate that an HTLV-I-encoded protein acts as a transcriptional trans-activator in synovial cells. In this sense, the tax gene in the HTLV-I genome (26) is believed to function as a transcriptional trans-activator. Therefore, we compared the expression level ofthe tax gene in SCCs-I and -III. As shown in Fig. 5 , tax transcripts were detected in SCCs-I but not in SCC-III.
In vitro transfection analysis ofthe tax expressing plasmid into SCCs-IV. As shown in Table I , tax-expressing transfectants reached confluency within 37.4±2.8 d and c-fos, IL-I, , and IL-6 mRNAs were transactivated (Table I and data not shown).
Discussion
Recent studies have shown the existence of a large number of HTLV-I proviral copies in PBMCs of TSP/HAM (27) (28) (29) , and it is speculated that this significant viral load may play an important role in the pathogenesis of TSP/HAM. In addition, Kira et al. (29) reported that almost the same level of proviral load observed in TSP/HAM exists in PBMCs of HTLV-I carriers without TSP/HAM who suffered from autoimmune or inflammatory diseases. However, semiquantitative PCR analysis (29) showed that the proviral load of PBMCs derived from the three patients in this study was about 0.2-0.05% (data not shown). Nevertheless, we found that SCCs from patients with HAAP exhibited HTLV-I integration with high frequency, 30 .2%, 20.0%, and 25.6%, respectively. Moreover, 53.4% of integrated-SCCs developed to confluency within 60 d, whereas only 2.6% of nonintegrated SCCs reached confluency under the same conditions. Therefore, these findings suggest that integration by HTLV-I into synovial cells leads to acquisition ofa higher proliferative capacity. Accordingly, we compared the proliferative capacity of individual SCCs under the following conditions.
First, we cultured SCCs under semisolid conditions to assess anchorage-independent growth ability. We found that SCCs-I were capable of forming colonies at a higher rate than other types of SCCs. These data revealed that SCCs-I acquired the potential for autonomous proliferation. In addition, in spite of starvation conditions, SCCs-I were able to grow and c-fos, IL-1fI, and IL-6 mRNA were overexpressed in these cells. In particular, c-fos protooncogene is induced upon entry into the proliferative cycle in a wide variety ofcells (30) (31) (32) (33) (34) (35) (36) (37) and can be considered as a "universal" activation gene (38) . In addition, it is induced by p4Ot' through the cAMP-responding element-binding protein/activating transforming factor (CREB/ ATF) pathway (39, 40) . It may, therefore, be that overexpression of c-fos mRNA in integrated SCCs can account for enhanced cell proliferation through the CREB/ATF pathway. With respect to the overexpression of IL-I3 and IL-6, we have already reported that these inflammatory cytokines are constitutively produced in rheumatoid synovial cells and tightly associated with synovial cell proliferation in RA (15, 41-43). Therefore, it is possible that SCCs-I are not only able to grow autonomously but can also enhance the proliferation of other types of synovial cells through the paracrine pathway. Nevertheless, it is still possible that the detected proviral DNA may result from in vitro transmission from HTLV-I-infected T cells or synovial cells during the cloning procedure.
We have previously shown, however, that HTLV-I transmissibility to synovial cells was very low during a 12-d culture period ( 13 ) . It is, therefore, unlikely that this proviral DNA may be attributed to in vitro transmission ofHTLV-I. So far, it appears that the integration by HTLV-I plays an important role in promoting synovial cell proliferation in patients with HAAP and it may be that the high frequency of SCCs carrying proviral HTLV-I DNA in affected joints is a reflection of this higher proliferative capacity.
To clarify the mechanism of overexpression of these mRNAs, we determined their half-lives by treatment with actinomycin-D. The degradation rates ofthese mRNAs were not significantly different between SCCs-I and -II. Thus, these mRNAs were likely to be transcriptionally activated in SCCs-I. Transcriptional activation of these mRNAs was observed only in SCCs-I. These observations suggest that an HTLV-I-encoded protein might function as a transcriptional activator in synovial cells.
We also analyzed the manner of integration of HTLV-I into individual SCCs-I and determined their clonality. For this purpose, Southern blot analysis (44) has usually been applied (45) . However, the amount of DNA obtained from the SCCs was too small to be analyzed by Southern blot hybridization. We carried out the modified LM-PCR and were able to determine the unknown sequence adjoining the 5' HTLV-I LTR region using < 10 ng of genomic DNA. In ATL, monoclonal genomic integration ofproviral HTLV-I DNA has been demonstrated by Southern blot analysis (45) . On the other hand, we found that proviral HTLV-I DNA appeared to be randomly integrated into six representative SCCs-I that were obtained from the same HAAP patient. These results indicate that oligoor polyclonal HTLV-I integrated synovial cells proliferate in the affected synovium of patients with HAAP. In that these SCCs-I had almost the same proliferative capacity and exhibited a random manner of integration, we conclude that HTLV-I might act as a trans-activator rather than as a promoter of cis-activation of cellular genes by site-specific integration into synovial cells.
The study of half-lives of three kinds of mRNAs and the mode of HTLV-I integration also suggest that HTLV-I works as a transcriptional trans-activator. However, there is fairly general agreement that six or more kinds of protein are encoded in the HTLV-I genome (46, 47) . One of these, p40Ot is well known as a transcriptional trans-activator (26). We have already reported that HTLV-I tax/ rex mRNA could be detected in fresh synovial tissue and cultured T cell-depleted synovial cells but not in circulating fresh peripheral blood mononuclear cells or in fresh synovial fluid cells of HAAP patients ( 13). Furthermore, tax mRNA was preferentially expressed in the synovium of transgenic mice that carried the HTLV-I genome and exhibited synovial overgrowth resembling that seen in RA ( 14) . Thus, it is speculated that p40ta works to promote synovial cell proliferation in patients with HAAP. To provide further evidence to support this speculation, we compared the expression level of the tax gene between SCCs-I and -III. Although SCCs-III carried proviral HTLV-I DNA as did SCCs-I, SCCs-III had neither an enhanced growth ability nor detectable tax mRNA. Further study are required to explain why tax mRNA could be detected in SCCs-I but not in SCCs-III. Our observation, however, suggests that p4Oax, acting as a transcriptional trans-activator, plays a central role in the acquisition of enhanced growth capacity in synovial cells.
For greater understanding of the role of the tax gene in synovial cells, we carried out in vitro transfection of SCCs-IV, which are nonintegrated and unconfluent SCCs. We found that tax-expressing transfectants were capable ofgrowing factor and developing to confluency. In addition, mRNAs for c-fos, IL-I 3, and IL-6 appeared to be transcriptionally trans-activated.
Based on our observation, the HTLV-I tax gene likely causes the synovial cell proliferation observed in patients with HAAP.
It has previously been demonstrated that products of the tax gene are able to trans-activate not only the viral LTR (26, 48-51 ) but also many specific cellular genes. The Tax protein has been shown to activate transcription of the genes for IL-2 (52) (53) (54) , the a chain of IL-2 receptor (IL-2Ra) (55-58), graulocyte-macrophage colony-stimulating factor (59-62), nerve growth factor (NGF) (63), vimentine (64) , and c-fos protooncogene (39) . In CD4+ T lymphocytes, it has been postulated that the tax gene plays an important role in leukemogenesis through the IL-2/IL-2Ra autocrine pathway (65, 66) . Furthermore, activation of NF-K B/Rel likely is involved in leukemogenesis, since Tax trans-activation of the genes for both IL-2 and IL-2Ra requires induction ofNF-K B/ Rel (54, 55, 57, 58) . Also, Grassmann et al. (57, 58) reported that tax function is essential and sufficient in itself for immortalization of primary human CD4+ cord blood lymphocytes in culture in the context ofthe herpesvirus saimiri vector. Recently, several lines of evidence suggest that the tax gene may involve nonlymphoid cell proliferation. Overexpression of the tax gene in several rodent fibroblast cell lines leads to transformation of these cells (25) and coexpression of the tax gene with the ras oncogene transforms primary rat fibroblasts (69) . Furthermore, Smith and Greene (40) reported that transcriptional activation through the CREB/ATF pathway may play an important role in these Tax-mediated cellular transformations. Moreover, tax gene expression causes mesenchymal tumors (70) , neurofibromatosis (71) , and synovial overgrowth (14) in various transgenic mouse models. Green (63) speculated that Tax activation of the NGF/NGF receptor autocrine pathway may be involve in the development of neurofibromatosis in transgenic mice. In this report, we found that HTLV-I tax is responsible for the growth of synovial cells in humans. Further investigation is required to determine how the tax gene triggers synovial cell proliferation. This is, however, the first report that clearly describes a biological function for the tax gene in nonlymphoid cell proliferation in humans. We therefore believe that these findings may lead to a deeper understanding of not only this novel biological function of the HTLV-I tax gene but also of the pathogenesis of HTLV-I-associated diseases.
